ロード中...
Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab
Sarcopenia is a muscle loss syndrome known as a risk factor of various carcinomas. The impact of sarcopenia and sarcopenia-related inflammatory/nutritional markers in metastatic urothelial carcinoma (mUC) treated with pembrolizumab was unknown, so this retrospective study of 27 patients was performe...
保存先:
| 出版年: | Diagnostics (Basel) |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7277993/ https://ncbi.nlm.nih.gov/pubmed/32429323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics10050310 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|